• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Research Update: France-Based Clinical Laboratory Operator Cerba Assigned 'B+' Long-Term Rating; Outlook Stable Feb 13 Product Image

Research Update: France-Based Clinical Laboratory Operator Cerba Assigned 'B+' Long-Term Rating; Outlook Stable Feb 13

  • ID: 2417590
  • February 2013
  • Standard & Poors

FEATURED COMPANIES

  • Cerba European Lab SAS
  • MORE

Abstract
France-based clinical laboratory operator Cerba European Lab SAS (Cerba) has issued ?365 million of notes to refinance its bank debt. We assess Cerba's financial risk profile as "highly leveraged" and its business risk profile as "fair." We are assigning our 'B+' long-term corporate credit rating to Cerba. The stable outlook reflects our view that Cerba's market position, increasing scale, and operating model should enable it to sustain its operating performance and cash flow generation. On Feb. 18, 2013, Standard & Poor's Ratings Services assigned its 'B+' long-term corporate credit rating (CCR) to France-based clinical laboratory operator Cerba European Lab SAS (Cerba). The outlook is stable. At the same time, we assigned our 'B+' issue rating to Cerba's ?365 million senior...

Companies mentioned in this report are:
- Cerba European Lab SAS

Action: New Rating
Action: Outlook: Stable

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the READ MORE >

Note: Product cover images may vary from those shown

- Cerba European Lab SAS

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS